SIA FUNDS, EL FONDO QUE CONFÍA EN GRÍFOLS SE POSICIONA EN CONTRA DE LA OPA .
04 septiembre 2009
Verified by Johnson & Johnson , 2 sept 09 . Fase III Safety and Effectiveness of Trabetedin Versus Doxorubicin-based Chemotherapy ( TRS ) .
A Study of the Safety and Effectiveness of Trabetedin Versus Doxorubicin-based Chemotherapy in Patients With Translocation-Related Sarcomas (TRS).
...
‹
›
Inicio
Ver versión web